In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by ...
MedPage Today on MSN
CDC Backs Twice-Yearly Injectable for HIV Prevention
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...
The Print on MSN
HIV prevention jab in India soon at fraction of US cost? 2 drugmakers set to roll out generics
Year's supply of injectable to cost Rs 3,549, compared to over Rs 17 lakh in US. Powerful alternative to daily oral PrEP, ...
To reduce the spread of sexually transmitted diseases, the U.S. Centers for Disease Control and Prevention has proposed recommending a common antibiotic be taken after having unprotected sex. Under ...
A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.
Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...
According to the World Health Organization (WHO), lenacapavir offers a highly effective, long-acting alternative to daily ...
4d
Gilead drug deal opens door for $40-a-year generic version of groundbreaking HIV prevention overseas
Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, ...
Drug can be used to prevent catching the virus and treat those who have it Kampala, Uganda | THE INDEPENDENT & AGENCIES | A ...
Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback